Pay in 4 interest-free payments of $5.10 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Cells were seeded in 96-well plates at 2 10 5 cells/well unless otherwise indicated
Ozempic/Wegovy : Approximately 50% more effective than semaglutide-based alternatives Real-world data : Patients on Mounjaro are 3 times more likely to achieve 15% body weight loss compared to semaglutide users Dual-Action Mechanism Unlike single-action medications (Ozempic/Wegovy), Mounjaro works on both GLP-1 and GIP receptors , providing: Enhanced appetite suppression Improved blood sugar control Better insulin sensitivity Sustained weight loss maintenance Diabetes Management For type 2 diabetes patients, Mounjaro: Effectively lowers blood glucose levels Reduces insulin requirements in combination therapy Improves cardiovascular outcomes Supports long-term metabolic health Side Effects and Safety Considerations Common Side Effects Most Canadians tolerate Mounjaro well, with side effects typically subsiding within 24 weeks: Nausea (most common, usually temporary) Diarrhea or constipation Vomiting Reduced appetite Indigestion Management Tips : Taking Mounjaro with food, staying hydrated, and gradual dose escalation minimize gastrointestinal discomfort
Has your provider changed your dose
Dose & Timing Loading phase (optional): 20 g/day for 5 days, followed by 3-5 g/day maintenance
